尿素激酶和复合组织类型等离子体激活剂在心室内出血中的比较疗效
Kiyoon Yang1, Kyung Hwan Kim1, Heewon Jeong1
1Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Neurosurgical review
|May 30, 2025
概括
重组组织类型等离子体激活剂 (r-tPA) 加快了静脉内出血 (IVH) 清除,但没有改善长期结果. 最初的神经状态仍然是自发性脑内出血 (ICH) 患者的关键预测指标.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 自发性脑内出血 (ICH) 与心室内出血 (IVH) 携带死亡和严重残疾的高风险.
- 有效的IVH管理策略对于改善患者的治疗结果至关重要.
研究的目的:
- 在IVH患者中,比较尿激酶类型等离子体激活剂 (uPA) 和复合组织类型等离子体激活剂 (r-tPA) 的疗效.
- 评估这些治疗对功能结果和IVH清除率的影响.
主要方法:
- 在2014年1月至2024年2月期间接受IVH治疗的97名患者的回顾性分析.
- 患者通过外部心室排水 (EVD) 接受uPA或r-tPA.
- 在180天后,使用修改的兰金尺度 (mRS) 评估了功能性结果;分析了预后因素.
主要成果:
- 在uPA和r-tPA组之间180天mRS结果没有显著差异 (P=0.817).
- r-tPA显著更快的IVH清除 (P=0.022) 与较短的治疗和排水时间.
- 最初的ICH数量和NIHSS得分被确定为结果的关键预测因素.
结论:
- 虽然r-tPA加速了IVH清除,但它没有增强长期功能恢复.
- 使用r-tPA的更快清除可能会降低ICU停留和感染率.
- 需要进一步的大规模研究来验证这些发现,并探索r-tPA在IVH管理中的作用.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
48
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
48
Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K


